FDA Approved: SYNAGIS — Supplemental Application (Swedish Orphan Biovitrum AB (publ))

View source ↗

Summary

FDA approved a supplemental application for Synagis (palivizumab) from Swedish Orphan Biovitrum AB, indicating an approved change to the product’s labeling or i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• Synagis (palivizumab)

Snippet

SUPPL AP for SYNAGIS (PALIVIZUMAB)